New York Daily News Examines Growing Use of Misoprostol To End Pregnancy
Main Category: Pregnancy / ObstetricsArticle Date: 13 Oct 2005 - 0:00 PDT
|
|
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
The New York Daily News on Sunday examined the growing "notoriety" of the ulcer treatment drug misoprostol, which also is used in medical abortion procedures to induce uterine contractions. The drug -- by G.D. Searle and Pfizer and sold under the brand name Cytotec -- has become "well-known in poor, immigrant communities in New York and abroad as a cheap and private way to end" an unplanned pregnancy, according to the Daily News. An 800-microgram dose of misoprostol is 60% to 90% effective at ending a pregnancy when taken alone within the first seven weeks' gestation. The drug has been used legally for years in an FDA-approved regimen that includes mifepristone. "Drano [-- the drain clog remover --] is probably the one thing cheaper, but I wouldn't recommend it," New York State Right to Life Committee spokesperson Lori Kehoe said referring to the $1 cost of the pill, adding, "Regardless of price, the ultimate cost is one human life at least and possibly two." Jennifer Blum of Gynuity Health Projects, a New York not-for-profit that supports access to abortion, said, "Any time women are resorting to back-street, illegal abortions, it's never as safe as a procedure done under a doctor's supervision," but she added that while "[m]isoprostol is not an end-all solution, ... it's definitely the cheapest and easiest method" (Dillon, New York Daily News, 10/9).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pregnancy / obstetrics section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/31945.php>
APA
http://www.medicalnewstoday.com/releases/31945.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




